Han van de Waterbeemd

发表

Chemometric methods in molecular design

Han van de Waterbeemd, H. Waterbeemd, 1995 .

Advanced Computer-Assisted Techniques in Drug Discovery: van de Waterbeemd/Advanced

Han van de Waterbeemd, 1994 .

Substructure and whole molecule approaches for calculating log P

Han van de Waterbeemd, Raimund Mannhold, R. Mannhold, 2001, J. Comput. Aided Mol. Des..

Computer-Assisted Lead Finding and Optimization

Han van de Waterbeemd, Gerd Folkers, Bernard Testa, 1997 .

Lipophilicity in PK design: methyl, ethyl, futile

Han van de Waterbeemd, Dennis A. Smith, Barry C. Jones, 2001, J. Comput. Aided Mol. Des..

Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric

Han van de Waterbeemd, H. Waterbeemd, 1995 .

QSAR Modeling Using Automatically Updating Correction Libraries: Application to a Human Plasma Protein Binding Model

Han van de Waterbeemd, Andrew M. Davis, Sarah L. Rodgers, 2007, J. Chem. Inf. Model..

ADME-Tox approaches

Han van de Waterbeemd, Bernard Testa, B. Testa, 2007 .

Pattern recognition study of QSAR substituent descriptors

Han van de Waterbeemd, Bernard Testa, Pierre-Alain Carrupt, 1989, J. Comput. Aided Mol. Des..

Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors

Han van de Waterbeemd, Gerd Folkers, Oleg A. Raevsky, 1996 .

Multivariate data modeling of new steric, topological and CoMFA-derived substituent parameters

Han van de Waterbeemd, Bernard Testa, Lemont B. Kier, 1993 .

Time‐Series QSAR Analysis of Human Plasma Protein Binding Data

Han van de Waterbeemd, Andrew M. Davis, Sarah L. Rodgers, 2007 .

Structural effects in the lipophilicity of di- and polysubstituted benzenes as measured by reversed-phase high-performance liquid chromatography

Han van de Waterbeemd, Bernard Testa, Anna Tsantili-Kakoulidou, 1987 .

Which in vitro screens guide the prediction of oral absorption and volume of distribution

Han van de Waterbeemd, H. Waterbeemd, 2005 .

Simulation models for drug disposition and drug interactions

Han van de Waterbeemd, Maurice Dickins, H. Waterbeemd, 2004 .

Pharmacokinetics and Metabolism in Drug Design: SMITH: PHARMACOKINETICS AND METABOLISM IN DRUG DESIGN O-BK

Han van de Waterbeemd, H. Waterbeemd, D. Walker, 2006 .

The History of Drug Research: From Hansch to the Present

Han van de Waterbeemd, H. Waterbeemd, 1992 .

In Silico Prediction of Human Bioavailability

Han van de Waterbeemd, David J. Livingstone, D. Livingstone, 2008 .

Programs and Methods for Calculation of log P‐values

Han van de Waterbeemd, Raimund Mannhold, R. Mannhold, 1996 .

Lipophilicity in Drug Action and Toxicology: Pliška/Lipophilicity

Han van de Waterbeemd, Bernard Testa, V. Pliska, 1996 .

Lipophilicity in drug action and toxicology

Han van de Waterbeemd, Bernard Testa, V. Pliska, 1996 .

The QSAR and Modelling Society

Han van de Waterbeemd, Hugo Kubinyi, H. Kubinyi, 1996 .

Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics

Han van de Waterbeemd, H. Waterbeemd, K. Beaumont, 2001 .

Chapter 37 - Glossary of Terms Used in Computational Drug Design (IUPAC Recommendations 1997)

Han van de Waterbeemd, Peter Willett, Gérard Grassy, 1998 .

Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability

Han van de Waterbeemd, Hans Lennernäs, Per Artursson, 2003 .

Pharmacokinetics and metabolism in drug design

Han van de Waterbeemd, H. Waterbeemd, D. Walker, 2001 .

Multivariate Data Analysis of Chemical and Biological Data

Han van de Waterbeemd, Martyn G. Ford, James Devillers, 1995 .